{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:41:44Z","timestamp":1777866104104,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Plaque disruption and subsequent healing are important contributors to coronary plaque progression; however, the biological mechanisms underlying this process remain incompletely understood. Optical coherence tomography (OCT) enables the identification of previously disrupted plaques, referred to as layered plaques. Proteomic analysis can characterize the molecular signature of layered plaques, providing insights into the biology of plaque disruption and healing. Furthermore, layered plaques indicate a more advanced stage of atherosclerotic disease, and their noninvasive identification could enhance patient risk stratification. This study aimed to identify plasma proteins associated with layered plaques at the culprit lesion in patients with stable angina pectoris (SAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients undergoing coronary angiography and OCT for SAP, with periprocedural blood sample collection, were enrolled. A proteomic analysis was subsequently performed, assessing 1470 proteins using the Olink explore 1536 reagent kit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 51 patients, OCT identified 31 (60.8%) patients with layered plaques at the culprit lesion. Patients with layered plaques exhibited 2.23- and 2.11-fold higher concentrations of interleukin-17A (IL17A) and matrix metalloproteinase-1 (MMP1), respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.013 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001), compared to those without layered plaques. Multivariable regression models demonstrated that IL17A and MMP1 were associated with layered plaques independent of known predictors (diameter stenosis &gt; 70%, B2\/C American College of Cardiology\/American Heart Association lesion, and multivessel disease). Adding both proteins to the known predictors significantly improved the area under the curve (AUC) for layered plaque detection (AUC 0.831 vs. 0.581;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with SAP, IL17A, and MMP1 were independently associated with layered plaques identified by OCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001593","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:01:15Z","timestamp":1763553675000},"page":"271-279","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Matrix metalloproteinase-1 and interleukin-17A are associated with previous plaque disruption: a combined proteomics and optical coherence tomography study"],"prefix":"10.1097","volume":"37","author":[{"given":"Marco","family":"Covani","sequence":"first","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Cardiology Department, University Hospital of Parma, Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Niccoli","sequence":"additional","affiliation":[{"name":"Cardiology Department, University Hospital of Parma, Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Niida","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyasu","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Scalamera","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"},{"name":"Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunao","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kawasaki Saiwai Hospital, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kawasaki Saiwai Hospital, Kawasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kahraman","family":"Tanriverdi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Vergallo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genova, Italy"},{"name":"Cardiothoracic and Vascular Department (DICATOV), Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Italo","family":"Porto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties (DIMI), University of Genoa, Genova, Italy"},{"name":"Cardiothoracic and Vascular Department (DICATOV), Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"McNulty","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Yonetsu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ik-Kyung","family":"Jang","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"R1-20260430","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/hrt.82.3.265","article-title":"Mechanisms of progression in native coronary artery disease: role of healed plaque disruption.","volume":"82","author":"Mann","year":"1999","journal-title":"Heart"},{"key":"R2-20260430","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMra2000317","article-title":"Atherosclerotic plaque healing.","volume":"383","author":"Vergallo","year":"2020","journal-title":"N Engl J Med"},{"key":"R3-20260430","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11239-020-02116-5","article-title":"Predictors for layered coronary plaques: an optical coherence tomography study.","volume":"50","author":"Araki","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R4-20260430","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the mechanisms of acute coronary syndromes.","volume":"124","author":"Libby","year":"2019","journal-title":"Circ Res"},{"key":"R5-20260430","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy.","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"R6-20260430","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11239-020-02076-w","article-title":"Clinical significance of healed plaque detected by optical coherence tomography: a 2-year follow-up study.","volume":"50","author":"Kurihara","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R7-20260430","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jcmg.2020.08.014","article-title":"Predictors of rapid plaque progression: an optical coherence tomography study.","volume":"14","author":"Araki","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"R8-20260430","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.atherosclerosis.2018.05.025","article-title":"In vivo optical coherence tomography imaging and histopathology of healed coronary plaques.","volume":"275","author":"Shimokado","year":"2018","journal-title":"Atherosclerosis"},{"key":"R9-20260430","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","article-title":"Optical coherence tomography in coronary atherosclerosis assessment and intervention.","volume":"19","author":"Araki","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"R10-20260430","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1161\/ATVBAHA.120.314298","article-title":"Healed plaques in patients with stable angina pectoris.","volume":"40","author":"Russo","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R11-20260430","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2018.10.093","article-title":"Healed culprit plaques in patients with acute coronary syndromes.","volume":"73","author":"Fracassi","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R12-20260430","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s11239-024-02982-3","article-title":"Layered plaque is associated with high levels of vascular inflammation and vulnerability in patients with stable angina pectoris.","volume":"57","author":"Niida","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"R13-20260430","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcmg.2021.10.014","article-title":"Plaque rupture, compared with plaque erosion, is associated with a higher level of pancoronary inflammation.","volume":"15","author":"Nakajima","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"R14-20260430","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/01.CIR.99.19.2503","article-title":"Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques.","volume":"99","author":"Sukhova","year":"1999","journal-title":"Circulation"},{"key":"R15-20260430","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/01.CIR.96.2.396","article-title":"Activation of monocyte\/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.","volume":"96","author":"Mach","year":"1997","journal-title":"Circulation"},{"key":"R16-20260430","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/ATVBAHA.112.300827","article-title":"Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress.","volume":"33","author":"Koskinas","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R17-20260430","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.amjcard.2003.08.061","article-title":"Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome.","volume":"92","author":"Inoue","year":"2003","journal-title":"Am J Cardiol"},{"key":"R18-20260430","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1067\/mhj.2001.112238","article-title":"Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.","volume":"141","author":"Inokubo","year":"2001","journal-title":"Am Heart J"},{"key":"R19-20260430","doi-asserted-by":"crossref","first-page":"1101.e1","DOI":"10.1016\/j.ahj.2006.02.029","article-title":"Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction.","volume":"151","author":"Cavusoglu","year":"1101","journal-title":"Am Heart J"},{"key":"R20-20260430","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.atherosclerosis.2015.01.003","article-title":"Relation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography.","volume":"239","author":"Cavusoglu","year":"2015","journal-title":"Atherosclerosis"},{"key":"R21-20260430","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside.","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R22-20260430","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2012.02.117","article-title":"Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice.","volume":"420","author":"Usui","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20260430","doi-asserted-by":"crossref","first-page":"196ra100","DOI":"10.1126\/scitranslmed.3006133","article-title":"Transforming growth factor-\u03b2 signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway.","volume":"5","author":"Gister\u00e5","year":"2013","journal-title":"Sci Transl Med"},{"key":"R24-20260430","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques.","volume":"220","author":"de Boer","year":"2010","journal-title":"J Pathol"},{"key":"R25-20260430","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00395-010-0135-y","article-title":"Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.","volume":"106","author":"Erbel","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"R26-20260430","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00011-012-0510-2","article-title":"Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques.","volume":"61","author":"Liu","year":"2012","journal-title":"Inflamm Res"},{"key":"R27-20260430","doi-asserted-by":"crossref","first-page":"e72804","DOI":"10.1371\/journal.pone.0072804","article-title":"Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"R28-20260430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2022.04.011","article-title":"Differences of inflammatory cytokine profile in patients with vulnerable plaque: a coronary CTA study.","volume":"350","author":"Roesner","year":"2022","journal-title":"Atherosclerosis"},{"key":"R29-20260430","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/eurheartj\/ehs263","article-title":"Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction.","volume":"34","author":"Simon","year":"2013","journal-title":"Eur Heart J"},{"key":"R30-20260430","first-page":"e60980","article-title":"The impact of interleukin-17 inhibitors on major adverse cardiovascular events in psoriasis or psoriatic arthritis patients naive to biologic agents: a systematic review and meta-analysis of randomized controlled trials.","volume":"16","author":"Ni","year":"2024","journal-title":"Cureus"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:01:33Z","timestamp":1777536093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001593","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]}}}